Literature DB >> 36018426

MUW researcher of the month.

.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 36018426      PMCID： PMC9411829          DOI： 10.1007/s00508-022-02077-0

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   2.275


× No keyword cloud information.
  14 in total

1.  Determinants of COVID-19 disease severity in patients with cancer.

Authors:  Ying Taur; Mini Kamboj; Elizabeth V Robilotti; N Esther Babady; Peter A Mead; Thierry Rolling; Rocio Perez-Johnston; Marilia Bernardes; Yael Bogler; Mario Caldararo; Cesar J Figueroa; Michael S Glickman; Alexa Joanow; Anna Kaltsas; Yeon Joo Lee; Anabella Lucca; Amanda Mariano; Sejal Morjaria; Tamara Nawar; Genovefa A Papanicolaou; Jacqueline Predmore; Gil Redelman-Sidi; Elizabeth Schmidt; Susan K Seo; Kent Sepkowitz; Monika K Shah; Jedd D Wolchok; Tobias M Hohl
Journal:  Nat Med       Date:  2020-06-24       Impact factor: 53.440

2.  SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center.

Authors:  Julia M Berger; Margaretha Gansterer; Wolfgang Trutschnig; Arne C Bathke; Robert Strassl; Wolfgang Lamm; Markus Raderer; Matthias Preusser; Anna S Berghoff
Journal:  Wien Klin Wochenschr       Date:  2021-08-19       Impact factor: 1.704

3.  SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic.

Authors:  Anna S Berghoff; Margaretha Gansterer; Arne C Bathke; Wolfgang Trutschnig; Philipp Hungerländer; Julia M Berger; Judith Kreminger; Angelika M Starzer; Robert Strassl; Ralf Schmidt; Harald Willschke; Wolfgang Lamm; Markus Raderer; Alex D Gottlieb; Norbert J Mauser; Matthias Preusser
Journal:  J Clin Oncol       Date:  2020-08-14       Impact factor: 44.544

4.  Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours.

Authors:  Maximilian J Mair; Sahra Pajenda; Aysegül Ilhan-Mutlu; Ariane Steindl; Barbara Kiesel; Georg Widhalm; Karin Dieckmann; Katharina Feldmann; Johannes Hainfellner; Christine Marosi; Leonhard Müllauer; Ludwig Wagner; Matthias Preusser; Anna S Berghoff
Journal:  ESMO Open       Date:  2020-11

5.  Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study.

Authors:  Maximilian J Mair; Julia M Berger; Manfred Mitterer; Margaretha Gansterer; Arne C Bathke; Wolfgang Trutschnig; Anna S Berghoff; Thomas Perkmann; Helmuth Haslacher; Wolfgang W Lamm; Markus Raderer; Selma Tobudic; Thorsten Fuereder; Thomas Buratti; Dominic Fong; Matthias Preusser
Journal:  Eur J Cancer       Date:  2022-02-07       Impact factor: 9.162

6.  SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria : Findings of a multicentric nationwide study.

Authors:  Julia M Berger; Phillipp Wohlfarth; Oliver Königsbrügge; Hanna A Knaus; Edit Porpaczy; Hannes Kaufmann; Johanna Schreiber; Tatevik Mrva-Ghukasyan; Thomas Winder; Luciano Severgnini; Dominik Wolf; Verena Petzer; Van Anh Nguyen; Georg Weinlich; Leopold Öhler; Anna Wonnerth; Aurelia Miksovsky; Bert Engelhart; Matthias Preusser; Anna S Berghoff
Journal:  Wien Klin Wochenschr       Date:  2022-02-16       Impact factor: 2.275

7.  Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron.

Authors:  Maximilian J Mair; Manfred Mitterer; Pia Gattinger; Julia M Berger; Wolfgang Trutschnig; Arne C Bathke; Margaretha Gansterer; Anna S Berghoff; Severin Laengle; Lynn Gottmann; Thomas Buratti; Helmuth Haslacher; Wolfgang W Lamm; Markus Raderer; Selma Tobudic; Thorsten Fuereder; Rudolf Valenta; Dominic Fong; Matthias Preusser
Journal:  Cancer Cell       Date:  2022-04-12       Impact factor: 38.585

8.  High levels of anti-SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine.

Authors:  Dominic Fong; Maximilian J Mair; Manfred Mitterer
Journal:  Eur J Cancer       Date:  2021-06-11       Impact factor: 9.162

9.  Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).

Authors:  Astrid Lièvre; Anthony Turpin; Isabelle Ray-Coquard; Karine Le Malicot; Juliette Thariat; Guido Ahle; Cindy Neuzillet; Xavier Paoletti; Olivier Bouché; Kais Aldabbagh; Pierre Michel; Didier Debieuvre; Anthony Canellas; Marie Wislez; Lucie Laurent; May Mabro; Raphael Colle; Anne-Claire Hardy-Bessard; Laura Mansi; Emeline Colomba; Jean Bourhis; Philippe Gorphe; Yoann Pointreau; Ahmed Idbaih; Renata Ursu; Anna Luisa Di Stefano; Gérard Zalcman; Thomas Aparicio
Journal:  Eur J Cancer       Date:  2020-10-08       Impact factor: 9.162

10.  SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.

Authors:  Thorsten Fuereder; Anna Sophie Berghoff; Gerwin Heller; Helmuth Haslacher; Thomas Perkmann; Robert Strassl; Julia Maria Berger; Hannah Christina Puhr; Judith Kreminger; Florian Moik; Lorenz Schubert; Angelika Martina Starzer; Ariane Steindl; Stefan Winkler; Matthias Preusser; Selma Tobudic
Journal:  ESMO Open       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.